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Key Points 
 
 The carotid body has been proposed to be an acute sensor of hypoglycaemia, 
although conflicting data exists regarding the ability of hypoglycaemia to stimulate the 
carotid body directly. The reason for these discrepancies is not known. 
 
 In an in vitro, freshly isolated, intact rat carotid body preparation, chemoafferent 
function was unaffected and protected against metabolic injury for 30 minutes 
exposure to glucose deprivation. 
 
 Glycogen granules and glycogen conversion enzymes were identified in type I cells 
and targeting of glycogenolysis or functional glycogen depletion both caused a more 
rapid run down of glycolysis during glucose deprivation. 
 
 This shows that glycogen maintains carotid body sensory neuronal output in periods 
of restricted glucose delivery to protect the metabolic integrity of the organ during 
hypoglycaemia.  
 
 The preservation of energetic status may account for the variation in the reported 
capacity of the carotid body to sense physiological glucose concentrations. 
 
 
144 Words
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Abstract 
 
The view that the carotid body (CB) type I cells are direct physiological sensors of 
hypoglycaemia is challenged by the finding that the basal sensory neuronal outflow from the 
whole organ is unchanged in response to low glucose. The reason for this difference in 
viewpoint and how the whole CB maintains its metabolic integrity when exposed to low 
glucose is unknown. Here we show that, in the intact superfused rat CB, basal sensory 
neuronal activity was sustained during glucose deprivation for 29.1±1.2 minutes, before 
irreversible failure following a brief period of excitation. Graded increases in the basal 
discharge induced by reducing the superfusate PO2, led to proportional decreases in the 
time to the pre-failure excitation during glucose deprivation which was dependent on a 
complete run-down in glycolysis and a fall in cellular energy status. A similar ability to 
withstand prolonged glucose deprivation was observed in isolated type I cells. Electron 
micrographs and immunofluorescent staining of rat CB sections revealed the presence of 
glycogen granules and the glycogen conversion enzymes, glycogen synthase I and glycogen 
phosphorylase BB, dispersed throughout the type I cell cytoplasm. Furthermore, 
pharmacological attenuation of glycogenolysis and functional depletion of glycogen both 
significantly reduced the time to glycolytic run-down by ~ 33% and 65% respectively. These 
findings suggest that type I cell glycogen metabolism allows for the continuation of glycolysis 
and the maintenance of CB sensory neuronal output in periods of restricted glucose delivery 
and this may act as a key protective mechanism for the organ during hypoglycaemia. The 
ability, or otherwise, to preserve energetic status may thus account for variation in the 
reported capacity of the CB to sense physiological glucose concentrations and may even 
underlie its function during pathological states associated with augmented CB discharge.    
 
Abbreviations 
 
CB - carotid body. DAB - 1, 4-Dideoxy-1, 4-imino D-arabinitol hydrochloride.  
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Introduction 
 
The mammalian carotid body (CB) is a highly specialised, neural crest derived, peripheral 
sensory organ that responds acutely to a number of important stress stimuli that have 
classically included hypoxia, hypercapnia and acidosis (Kumar & Prabhakar, 2012). 
Stimulation of the CB and activation of adjacent sensory neurones induces a series of well-
characterised reflex responses including hyperventilation, tachycardia and systemic 
vasoconstriction that promotes corrective regulation of arterial blood gases and the 
maintenance of adequate metabolism in the brain and vital organs (Kumar, 2009). Chronic 
up-regulation of the CB sensory neuronal activity as occurs during obstructive sleep apnoea 
(Lesske et al., 1997) is emerging as an important driving force in establishing the raised 
arterial blood pressure associated with type II diabetes (Ribeiro et al., 2013) as well as 
chronic heart failure (Schultz et al., 2013), sleep disordered breathing (Narkiewicz et al., 
1998), and spontaneous hypertension (McBryde et al., 2013).   
 
The CB also has an important role in re-establishing normal plasma glucose concentrations 
in response to systemic hypoglycaemia (Alvarez-Buylla & de Alvarez-Buylla, 1988; Koyama 
et al., 2000; Wehrwein et al., 2010). CB regulation of glucose homeostasis is dependent on 
an augmentation in the sensory neuronal outflow, transmitted into the CNS, which promotes 
a downstream sympathetically mediated increase in adrenaline release from the adrenal 
medulla. Whether the CB is stimulated directly by low glucose or by a neuroendocrine factor 
released as a consequence of hypoglycaemia remains controversial, with a number of 
discrepancies reported regarding the direct low glucose sensitivity of the CB. Thus, the 
demonstration that CB thin slices or co-cultures of CB cells are acutely sensitive to 
physiological falls in glucose concentration (Pardal & Lopez-Barneo, 2002; Zhang et al., 
2007; Ortega-Saenz et al., 2013) have been countered by reports of the whole organ being 
insensitive to modest to severe, sustained reductions in glucose (Bin-Jaliah et al., 2004; 
Conde et al., 2007; Gallego-Martin et al., 2012). These differences have been suggested to 
result from the use of different CB preparations impacting variably upon the metabolic status 
of the tissue (Kumar, 2007). Notwithstanding this discrepancy, precisely how this sensory 
organ maintains adequate energy status during periods of reduced glucose is unknown but 
is of interest given the well-documented detrimental impact of hypoglycaemia on neuronal 
cell viability (Mohseni, 2001; Ozaki et al., 2010).   
 
No study has yet examined the functional importance of glycogen metabolism in sustaining 
CB type I cell viability and sensory neuronal activity during exposure to low glucose. In the 
CNS, astrocytic glycogen is broken down and released as lactate to fuel neuronal activity 
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and prevent cell death during periods of increased activity (Brown et al., 2003; Brown et al., 
2005), global ischaemia (Swanson et al., 1989) or glucose deprivation (Swanson & Choi, 
1993). It is also evident that Schwann cell glycogen metabolism is necessary to support 
axonal function in peripheral nerves during prolonged exposure to aglycaemia (Brown et al., 
2012). We therefore hypothesised that glycogen may have a valuable functional role in 
supporting neuronal and type I cell metabolism in the CB.      
 
This article presents novel data demonstrating the presence of glycogen granules and 
glycogen conversion enzymes in the CB type I cells. On exposure to low glucose, the 
sensory neuronal discharge frequency is not acutely disrupted, but is sustained due to the 
break-down of glycogen that drives glycolysis. In acute hypoxia, the absence of extracellular 
glucose consumption does not significantly impair the exponential rise in neuronal outflow or 
the rise in type I cell [Ca2+]i. These findings therefore emphasise the importance of a highly 
labile and functional metabolic reserve in the CB that may provide a mechanistic explanation 
for the discrepancies reported in the literature regarding a role for the CB in glucose sensing. 
In addition, these results provide insight into how peripheral sensory neuronal tissues may 
respond to metabolic stress evoked by pathologies predisposing to impaired glucose 
homeostasis and/or hypoxia.  
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Methods 
  
Surgical procedure and ethical approval 
CBs were isolated from adult male (50–200 g) Wistar rats for whole organ and imaging 
studies and from 10-12 day old Sprague Dawley rats for single cell studies (Pepper et al., 
1995; Buckler & Turner, 2013). All surgery was performed under inhalation anaesthesia (2-
4% isoflurane in O2). Following tissue procurement, animals were immediately killed by 
exsanguination or decapitation. All surgical procedures were performed in accordance with 
project and personal licences issued under the UK Animals (Scientific Procedures) Act 1986 
and were approved by the Biomedical Services Unit at the University of Birmingham and The 
University of Oxford. 
 
Extracellular recordings of CB sensory neuronal activity 
Extracellular recordings of single or few-fibre neurones were made from the cut end of the 
CSN using glass suction electrodes pulled from GC150-10 capillary glass (Harvard 
Apparatus, Kent, UK). The recorded voltage was band-pass filtered between 50 Hz and 50 
kHz (NeuroLog NL125; Digitimer, Welwyn Garden City, UK) and amplified with an AC 
amplifier (NeuroLog 105; Digitimer, Welwyn Garden City, UK). The superfusate PO2 was 
continuously measured using an O2 electrode (ISO2; World Precision Instruments, Hitchin, 
UK) and O2 meter (OXELP; World Precision Instruments, Hitchin, UK). The PO2 and 
chemoafferent derived voltage were both recorded using a CED micro1401 (Cambridge 
Electronic Design, Cambridge, UK). The chemoafferent voltage signal was sampled at 
15000 Hz and the PO2 at 100 Hz. Using the in-built wavemark analysis in the Spike2 
software (Cambridge Electronic Design, Cambridge, UK), electrical activity originating from a 
single neurone was determined by its unique „wavemark‟ signature based on action potential 
frequency, shape and amplitude.  
 
Flow meters with high precision valves (Cole Palmer Instruments, London, UK) were used in 
order to equilibrate the superfusate with a desired gas mixture. The superfusate PO2 was 
adjusted (at a fixed PCO2 of 40 mmHg) to set a normoxic basal frequency of 0.25–1.5 Hz. 
This is consistent with the single unit frequency previously recorded in vivo in arterial 
normoxia (Vidruk et al., 2001). To monitor chemoafferent responses to graded hypoxia the 
superfusate PO2 was gradually reduced at constant PCO2. During experimentation, CBs 
were continuously superfused with a standard bicarbonate buffered Krebs solution 
containing, in mM: 115 NaCl, 4.5 KCl, 1.25 NaH2PO4, 5 Na2SO4, 1.3 MgSO4, 24 NaHCO3, 
2.4 CaCl2 and 11 D-glucose. All solutions were heated to 37ºC and had a pH of 7.4. For 
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glucose free solutions, glucose was replaced with 11 mM mannitol to maintain constant 
osmolality. 
 
Immunohistochemistry 
Isolated CBs were fixed in 2.2% formaldehyde (TAAB Laboratories, Aldermaston, UK) in 
10 mM PBS, pH 7.4, containing 2% glucose and 0.02% sodium azide (Sigma-Aldrich, 
Gillingham, UK). The tissue was rinsed once in PBS and left in a 30% sucrose solution for 
24 hours before being embedded in frozen optimal cutting temperature compound (OCT; 
TAAB Laboratories, Aldermaston, UK). 10m thick tissue sections were cut using a cryostat 
and adhered onto charged glass slides (Thermo Scientific, Waltham, MA, USA). The tissue 
sections were permeabilised by incubation in PBS containing 1% Triton X-100 (Sigma-
Aldrich, Gillingham, UK). To limit non-specific antibody staining, tissue samples were 
incubated with PBS containing 1% BSA and 0.05% Tween20 (Sigma-Aldrich, Gillingham, 
UK).  
 
Tissue sections were incubated in a 0.1% BSA, 0.1% Tween20 PBS solution containing the 
appropriate primary antibodies, in a humidified chamber at 4C for 24 hours. Mouse 
monoclonal anti-rat tyrosine hydroxylase antibodies (Abcam, Cambridge, UK) were applied 
(1:20) for the positive identification of type I cells. In addition, rabbit monoclonal anti-rat 
glycogen synthase I (1:50; Abcam, Cambridge, UK) or rabbit polyclonal anti-human glycogen 
phosphorylase BB (1:100; AbD Serotec, Kidlington, UK) antibodies were applied to establish 
the presence or absence of enzymes capable of glycogen synthesis and metabolism.  
 
Tissue sections were washed in a 0.1% Tween20 PBS solution to remove excess primary 
antibodies and then incubated in a 0.1% BSA, 0.1% Tween20 PBS solution containing anti-
rabbit Alexa flura 488 (green) and anti-mouse Alexa flura 594 (red) (1:250; Molecular Probes, 
Paisley, UK) conjugated secondary antibodies to allow for subsequent fluorescent detection 
of the protein-immunoglobulin complexes. Images were viewed using an epifluorescent 
microscope (Zeiss, Cambridge, UK).  
 
Electron microscopy 
The whole CB was rapidly fixed in a 0.1M PBS buffered solution containing 5% 
glutaraldehyde (Sigma-Aldrich, Gillingham, UK) and 3% paraformaldehyde (Sigma-Aldrich, 
Gillingham, UK), for 2-3 hours. It was then post-fixed in a 1% osmium tetraoxide solution 
(Sigma-Aldrich, Gillingham, UK), for a further 1 hour. This specific staining protocol has been 
used previously to identify glycogen granules as „electron dense particles‟ in mouse liver 
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sections (Bendayan et al., 2009). The tissue was dehydrated by exposure to increasing 
concentrations of ethanol (50% - 100%) and then embedded in epoxy resin. Tissue thin 
sections were initially used to identify the CB under light microscopy. Ultrathin sections (30-
60 nm) of the CB were cut using an ultramicrotome with diamond knife and then stained with 
uranyl acetate and lead citrate. CB sections were viewed using a transition electron 
microscope operating at ~100 Kv at magnifications of x6000, x12000 and x25000. Type I 
cells were identified within clusters containing homogenous cells, each exhibiting a circular 
morphology and containing a large round central nucleus with abundant mitochondria.   
 
Type I cell isolation and measurements of [Ca2+]i 
Following isolation CBs were placed in ice-cold phosphate buffered saline. CBs were 
identified, dissected free and then transferred to a HAMS F-12 nutrient mixture, containing 
collagenase (0.4 mg / ml) and trypsin (0.2 mg / ml) and incubated at 37C, 5% CO2 and 11% 
O2, for 25-30 minutes. The tissue was then transferred to enzyme free DMEM/F12 culture 
media and triturated gently through fire polished pipettes. The resultant cell suspension was 
plated on to poly-l-lysine coated coverslips and maintained in an incubator at 37oC, 5% CO2 
& 11% O2 for between 2 and 8 hours before use. Culture media comprised  “Advanced 
DMEM/F-12” (Gibco, Paisley, UK) supplemented with 10% heat inactivated foetal bovine 
serum, 2 mM L-glutamine and 4 µg/ml insulin.  
 
[Ca2+]i was measured using Indo-1 loaded into cells by incubation with 2-5 μM of the 
acetoxymethyl ester derivative in culture media for 1 hr. at room temperature. Indo-1 was 
excited at 340 nm and fluorescence intensity measured at 405 ± 16 nm and 495 ± 10 nm. 
The fluorescence emission ratio (405/495) for Indo-1 was calibrated as previously described 
(Buckler & Vaughan-Jones, 1993). Fluorescence measurements were made using an 
inverted microscope (Nikon Diaphot 200; Nikon, Tokyo, Japan) equipped with a 100 W 
xenon lamp that provided the fluorescence excitation light source. Photomultiplier tubes 
(PMT; Thorn EMI, London, UK), cooled to minus 20C, were used to detect the emitted 
fluorescence. The output signal was fed through a current-voltage converter and the voltage 
was recorded using a CED micro1401 (Cambridge Electronic Design, Cambridge, UK) and 
visualised on a PC as an individual waveform. The voltage signal was sampled at 250 Hz. 
For glucose free solutions, glucose was replaced with 11 mM mannitol to maintain constant 
osmolality. Normoxic/hyperoxic solutions were equilibrated with 5% CO2 and 10% O2 (PO2 ~ 
80 mmHg). Hypoxic solutions were equilibrated with 5% CO2 and 95% N2.   
 
Analysis of data 
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Values are expressed as mean ± standard error of mean unless otherwise stated. Statistical 
analysis was performed using i) a paired 2-tailed student‟s t-test, ii) an un-paired 2-tailed 
student‟s t-test, iii) one way Analysis of Variance (ANOVA) or iv) repeated measures one 
way Analysis of Variance (ANOVA) with Bonferroni or Dunnett‟s post hoc analysis where 
appropriate (StatView version 5, Cary, NC, USA). Significance was taken as p<0.05.  
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Results 
 
Carotid body sensory activity during prolonged exposure to glucose deprivation. 
Initial experiments investigated the CB chemoafferent response to prolonged glucose 
deprivation. The superfusate PO2 was adjusted, in 11 mM glucose, to set a basal single fibre 
discharge frequency of between 0.25 and 1.5 Hz, consistent with the level previously 
recorded in vivo in arterial normoxia (Vidruk et al., 2001). On exposure to zero glucose, the 
basal chemoafferent discharge frequency was maintained for 29.1±1.2 minutes (N=8 fibres) 
and then increased significantly for a period of up to 10 minutes before failing irreversibly 
(Fig. 1A and 1B). In subsequent studies, the level of stimulation evoked by prolonged 
glucose deprivation was compared with that produced by severe hypoxia; a well-defined 
metabolic stimulus for the CB. Examples of the peak frequencies recorded for the same fibre 
in response to severe hypoxia and zero glucose are shown in Fig. 1C. Paired comparisons 
demonstrated that the peak level of chemoafferent excitation induced by prolonged glucose 
deprivation was less than 15% of that generated by severe hypoxia (Fig. 1D). 
 
We next determined whether an increase in basal action potential frequency and metabolic 
demand directly impacted on the time taken for the CB to respond to the glucose free 
stimulus. The superfusate PO2 was lowered to induce regulated, moderate elevations in 
basal discharge frequency, prior to glucose being removed from the superfusate. Example 
responses to glucose deprivation, recorded from fibres at three different levels of basal 
chemoafferent discharge frequency are shown in Fig. 2A. Regression analysis identified a 
strong correlation between the level of basal action potential discharge frequency and time 
taken to be stimulated upon exposure to zero glucose (R2=0.7, P<0.05) (Fig. 2B). This 
suggests that in the absence of external glucose delivery, an elevation in metabolic demand 
reduces the time that the CB can adequately support sensory neuronal output.  
 
Glycogen metabolism supports carotid body function in the absence of external 
glucose delivery 
The ability of the CB to sustain normal neuronal activity for up to 40 minutes in the absence 
of extracellular substrate delivery implies the presence of a considerable intracellular reserve 
of metabolic substrate/s. Given the important functional role of glycogen in the CNS (see 
Brown & Ransom, 2007) and peripheral nerves (Brown et al., 2012) it was hypothesised that 
glycogen may also be present in the CB and support both type I cell and neuronal activity 
during glucose deprivation. Immunohistochemical staining of 10 μm sections of CB tissue 
showed co-localisation of tyrosine hydroxylase (TH) (a classical type I cell marker) with both 
glycogen synthase I and the brain/neuronal isoform of glycogen phosphorylase BB in the CB 
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(Fig. 3A). Higher magnification confirmed co-localization within type I cell cytoplasm and also 
revealed a degree of staining outside type I cells for both glycogen conversion enzymes (Fig. 
3B). Imaging of the ultrastructure of the CB using electron microscopy detected glycogen 
granules abundantly dispersed throughout the cytoplasm of type I cells as well as within a 
neighbouring type II cell within a cluster (Fig. 3C). In these electron-micrographs, glycogen 
was visualised as small electron dense stained particles, up to 40 nm in diameter (Bendayan 
et al., 2009; Brown et al., 2012).  
 
To study a potential function of glycogen in the CB, experiments were performed using the 
glycogen phosphorylase inhibitor 1, 4-Dideoxy-1, 4-imino D-arabinitol hydrochloride 
(DAB)(Andersen et al., 1999). 100 M DAB was initially added during superfusion with 
11 mM glucose and this concentration was maintained throughout the glucose free exposure. 
An example response to glucose deprivation in the presence of DAB is shown in Fig. 4A. 
Peak stimulation evoked in the presence of DAB was not significantly different between 
groups; control 5.1 ± 1.2 Hz and DAB 3.3 ± 0.7 Hz. However, partial or complete inhibition of 
glycogen metabolism with DAB significantly reduced the time taken to respond to glucose 
free exposure by approximately 33% (Fig. 4B).  
 
Because of the unknown limitations of DAB diffusion, metabolism or uptake, further 
experiments were performed examining the chemoafferent response to glucose deprivation 
following exposure to hypoxia. In other tissues, hypoxia causes glycogen depletion (Niitsu et 
al., 1999) and increases the cellular AMP:ATP ratio (Evans et al., 2005); a key mechanism 
leading to allosteric activation of glycogen phosphorylase BB (Crerar et al., 1995). In the 
current study, the CB was subjected to either one or two periods of severe hypoxia (each 
lasting 4-5 minutes) in order to functionally deplete type I cell glycogen before removing the 
superfusate glucose. A chemoafferent response to zero glucose following two hypoxic 
episodes is demonstrated in Fig. 4C. The grouped results showed that one or two episodes 
of severe hypoxia significantly decreased the time taken to respond to glucose deprivation 
by approximately 40% and 65% respectively (Fig. 4D).  
 
Time dependent carotid body activation by low glucose is dependent on a run-down 
in glycolysis 
Inhibitory targeting of glycolysis, using sodium iodoacetate (100 M), evoked brief CB 
chemoafferent excitation followed by irreversible failure, with the peak single fibre frequency 
measuring 8.7 ± 1.1 Hz (N=12 fibres). This was perhaps not unexpected given that all known 
metabolic poisons and ATP depleting agents are known to produce intense CB activation. 
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However, it confirms the importance of glycolysis in maintaining type I cell and neuronal 
energy status under control conditions. During prolonged exposure to zero glucose, the time 
dependent chemoafferent stimulation and subsequent failure was also predicted to be a 
consequence of a reduction in the rate of glycolysis following complete depletion of glycogen. 
To test this directly, 5 mM lactate and 0.5 mM pyruvate (capable of bypassing glycolysis to 
generate ATP) were added to the superfusate following initiation of a response to the 
glucose free stimulus. In all fibres studied, addition of lactate and pyruvate rapidly restored 
the chemoafferent discharge frequency to basal levels within seconds (Fig. 5A & B). 
Additional experiments showed that adding back just 1 mM of glucose also rapidly reversed 
the stimulation induced by glucose deprivation (Fig. 5C & D). In the knowledge that the Km of 
the glucose transporters and hexokinase expressed in the CB are in the M range, re-
activation is likely to have occurred in the presence of 1 mM glucose, causing restoration of 
glycolysis. These data provide strong evidence that the chemoafferent stimulation in zero 
glucose is due to the termination of glycolysis following exhaustion of the glycogen reserve.  
 
The carotid body response to acute hypoxia is preserved during glucose deprivation  
CB glucose consumption is enhanced during hypoxia (Obeso et al., 1993). This suggests 
that the CB may become increasingly reliant on glucose uptake and glycolysis to counteract 
the hypoxia induced impairment of mitochondrial oxidative phosphorylation (Buckler & 
Turner, 2013). Here, paired neuronal responses to graded hypoxia were evaluated in the 
presence and absence of superfusate glucose and show that the characteristic exponential 
rise in chemoafferent discharge during hypoxia remains intact despite complete glucose 
deprivation (Fig 6A & B).   
 
In isolated type I cell clusters, zero glucose alone failed to cause any acute stimulation, 
showing consistency with the afferent nerve recordings, and confirming that the type I cells 
are able to withstand acute glucose deprivation without any disruption in energy status (Fig. 
6C & D). In addition, hypoxia induced [Ca2+]i elevations were unchanged after a 10 minute 
period of glucose free exposure (Fig. 6C & D), demonstrating that type I cell hypoxia 
chemotransduction pathways are preserved in spite of this sustained period of glucose 
deprivation.  
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Discussion 
 
We have shown that glycogen is present in the CB type I cell and that glycogen metabolism 
fuels glycolysis and maintains the CB chemoafferent activity during periods of prolonged 
glucose starvation. Glycogen metabolism also appears to be functionally important in 
sustaining the increase in neuronal activity induced by hypoxia. These findings therefore 
emphasise a valuable functional role for glycogen metabolism and glycolysis in supporting 
CB function and energy status upon exposure to potentially harmful metabolic stress stimuli.  
 
Glycogen sustains glycolysis and energy status during glucose deprivation 
Exposing the CB to complete glucose deprivation failed to cause any acute disruption in 
either type I cell [Ca2+]i or sensory neuronal output. Chemoafferent stimulation was observed 
but only after at least 20 minutes of glucose free exposure. We utilised a glucose free 
superfusate as the stimulus in our in vitro CB preparation, rather than a hypoglycemic one, 
to ensure that the stimulus presented to type-1 cells within the organ was consistent (i.e. 
zero). With a hypoglycemic perfusate extracellular glucose within the organ would be likely 
to vary considerably with organ size and glucose consumption rate. This strategy is similar to 
that employed by (Kholwadwala & Donnelly, 1992) who used anoxia when studying the 
effects of oxygen deprivation in the in vitro CB preparation to avoid variation in tissue 
oxygenation. It should be noted that we have found a number of factors influence the time 
delay between administering aglycaemia and observing a response. This argues that the 
delay is not simply an invariant wash out time for extracellular glucose but represents 
instead changes in the size and/or rate of utilisation of intracellular metabolic reserves. 
 
The rise in discharge frequency was also quickly restored to control levels by adding back 
just 1 mM glucose. Glycolysis is closely regulated by the activity of hexokinases. The 
absence of glucokinase (hexokinase IV) from CB type I cells (Garcia-Fernandez et al., 2007) 
however implies that glycolysis will only be impaired at very low concentrations of 
intracellular glucose since all other hexokinases have a very low (μM) Km for glucose (Lowry 
& Passonneau, 1964; Meglasson & Matschinsky, 1986). The return to a control level of 
discharge frequency in just 1 mM glucose is therefore consistent with a re-activation of 
glycolysis and although we cannot definitively show this through direct measure, it is highly 
likely that the type I cells within the whole organ were being exposed to a glucose 
concentration very close to zero. 
 
A similar restoration of chemoafferent activity during glucose free induced stimulation was 
achieved by adding lactate and pyruvate. These substrates are able to by-pass the glycolytic 
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pathway and rapidly enter the TCA cycle to drive ATP synthesis. Chemoafferent stimulation 
following prolonged glucose free conditions is therefore most likely to be due to a complete 
run-down in glycolysis leading directly to a fall in type I cell or neuronal energy status. 
Whether or not the increase in frequency is a consequence of type I cell activation (and 
transmitter release) or direct neuronal stimulation (following a run-down in the Na+/K+ 
ATPase) was beyond the scope of this study. That said, a metabolic signalling cascade in 
the type I cell is well defined and alterations in [AMP]i or [ATP]i have been linked to cellular 
depolarisation either through activation of AMP-activated kinase (cellular energy sensor) 
(Wyatt et al., 2007) or following a reduction in the ATP sensitive TASK-like channel 
conductance (Varas et al., 2007). 
 
The absence of acute neuronal excitation in zero glucose does suggest that the type I cells 
and afferent neurones maintain glycolysis and energy status for a considerable period of 
time. Without external glucose uptake, it is logical to hypothesise that glycolysis could be 
sustained by the metabolism of stored glycogen. CB glycogen content was not measured 
directly because of the small carotid body size in the rat (~ 200 g). However, glycogen was 
visualised in the type I cell using electron microscopy and it appeared to be localised in 
considerable quantities throughout the cytoplasm. Accordingly, the type I cells also positively 
expressed glycogen synthase I and glycogen phosphorylase BB, suggesting the ability to 
metabolise and synthesise glycogen depending on the specific energetic cellular 
requirements. Pharmacological targeting of glycogenolysis using DAB and functional 
glycogen depletion by hypoxia both significantly reduced the time taken for the CB to 
respond (and fail) to glucose deprivation. Thus, it is proposed that glycogen metabolism 
supports glycolysis in the CB during acute exposure to glucose deprivation. This function 
mimics that of glycogen in the CNS (Swanson & Choi, 1993) and peripheral nerves (Brown 
et al., 2012) and offers the CB metabolic protection against severe hypoglycaemia.  
 
We found that glycogen synthase I and glycogen phosphorylase BB were not solely limited 
to TH positive, type I cells. In addition, we found evidence of glycogen within type II cells. 
The type II cell has often been thought to act as a glial cell (Kumar & Prabhakar, 2012), so it 
is possible that it could also function as an important glycogen reserve in the CB.  Indeed we 
cannot exclude the possibility that other cellular elements within the organ, including nerve 
endings and vasculature, may also have glycogen reserves. These considerations make it 
difficult to predict the extent to which these different stores influence the response to glucose 
deprivation, but do not detract from our conclusion that it is the depletion of some of these 
stores that gives rise to sensitivity to glucose deprivation. 
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Interestingly, it appears that the duration of functional support offered by glycogen to 
chemoafferent or type I cell activity is more comparable with that seen in the CNS (~ 0.3 
hours) than in the peripheral nervous system (~ 2 hours). This could be representative of a 
particularly high type I cell or afferent neurone metabolic rate or an alteration in 
mitochondrial ATP generation. Intriguingly, the type I cell mitochondria exhibit fundamental 
differences in O2 affinity compared with other neuronal tissues (Buckler & Turner, 2013), but 
whether this impairs the ability to produce ATP in normoxia is still to be evaluated.  
 
Carotid body energy status in hypoxia 
Hypoxia causes type I cell depolarisation, [Ca2+]i elevation, neurosecretion and post-synaptic 
chemoafferent excitation (Kumar & Prabhakar, 2012). All of these processes would be 
expected to increase CB ATP utilisation and yet there is a wealth of evidence implying that 
the initial step in the hypoxia signalling cascade is impairment of mitochondrial energy 
metabolism (Duchen & Biscoe, 1992b, a; Buckler & Turner, 2013). Precisely how this tissue 
copes with an increase in ATP consumption despite a reduction in mitochondrial ATP 
generation is largely unknown. It has been observed that glucose consumption increases in 
hypoxia (Obeso et al., 1993) and is likely to enhance ATP generation through anaerobic 
glycolysis, allowing the CB to sustain a form of energetic competency. In our experiments, 
the absence of extracellular glucose for 10-15 minutes failed to restrict either the rise in 
chemoafferent discharge frequency or the increase in type I cell [Ca2+]i evoked by acute 
hypoxia. However, 1 or 2 episodes of severe and sustained (5 minutes) hypoxia made the 
CB significantly less tolerant to subsequent zero glucose exposure, causing a more rapid 
run-down in glycolysis, energy status and organ failure. In view of these findings it is likely 
that in hypoxia, an increase in glycogen metabolism is important in supporting a rise in 
glycolysis and allows for sufficient ATP to be generated to sustain type I cell depolarisation, 
[Ca2+]i elevation, neurosecretion and reuptake, even though oxidative phosphorylation is 
compromised. Selective manipulation of CB glycogen metabolism or glucose consumption 
may prove to be beneficial in restricting the heightened CB neuronal output and in patients 
with sleep disordered breathing or chronic heart failure. Whether or not glycogen storage or 
glucose metabolism is altered in the CB following chronic exposure to intermittent hypoxia or 
catecholamines may be an intriguing area for future examination.  
 
The carotid body in glucose homeostasis 
Our observations clearly suggest that the CB is not acutely or directly stimulated by low 
glucose. They thus confirm previous findings in the whole organ (Bin-Jaliah et al., 2004; 
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Conde et al., 2007; Gallego-Martin et al., 2012) but contradict reports that the CB is 
activated during acute glucose shortage in reduced preparations i.e. CB slices or isolated 
cells that were maintained in culture for at least 24 hr (Pardal & Lopez-Barneo, 2002; Zhang 
et al., 2007; Ortega-Saenz et al., 2013). We have however investigated both intact CBs and 
isolated type I cells and have found no evidence of acute glucose sensitivity in either so do 
not ascribe the contradictory nature of these data simply to the use of intact organs vs. 
reduced preparations. We would also exclude animal age as a factor; glucose sensitivity has 
been reported in preparations from both neonatal and adult rats (Garcia-Fernandez et al., 
2007; Zhang et al., 2007; Pardal & Lopez-Barneo, 2002) whereas we found no glucose 
sensitivity in either adult CB‟s or neonatal Type-1 cells. Cell/tissue culture may, however, be 
an issue since Gallego-Martin et al, 2012 reported that aglycaemia can augment secretory 
responses to hypoxia in intact rat CB‟s maintained in culture for 1 day but not in freshly 
isolated CB‟s which are acutely glucose insensitive. Whilst our main study has been 
conducted on acutely isolated organs and cells, we have also found that incubation of the 
whole CB in hyperoxia for a prolonged period (up to 24hr) significantly reduced the time 
taken for the CB to respond to zero glucose (data not shown). 
 
Whilst we have no mechanism to account for these discrepancies, our data is suggestive 
that the reason for the difference may lie with a run down of glycogen, or an inability to utilise 
glycogen, in reduced CB models that require incubation over a period of days following 
excision, such as thin CB slices and co-culture preparations. Alternatively, prolonged anoxia 
during the surgical procedures or within experimental protocols may induce an augmented 
glucosensitivity following exhaustion of type I cell glycogen. Indeed, in the whole in vitro, 
superfused cat CB, the only evidence of a response to zero glucose, as observed by an 
increase in the absolute level of acetylcholine release, was following and concomitant with a 
substantial exposure to severe hypoxia (Fitzgerald et al., 2009). In contrast, and somewhat 
in agreement with our findings, in the superfused and perfused in vitro cat CB preparation, 
responses to flow interruption were not augmented for at least 15 minutes of exposure to 
zero glucose (Spergel et al., 1992). A high level of superfusate PO2 used in our experiments 
does not appear to be the reason for differences noted, as we were careful with the in vitro 
whole organ preparation to use a level of PO2 that was related to physiological normoxia in 
vivo as evidenced by the basal chemodischarge as recorded by (Vidruk et al., 2001). 
Furthermore, isolated type I cells were bathed in a PO2 of around 80mmHg which was 
similar or slightly less than that used by both Pardal & Lopez-Barneo, 2002 and Zhang et al, 
2007.  
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In addition, the CB appears to be required for the restoration of normal plasma glucose 
concentrations in response to hypoglycaemia, both in animals (Alvarez-Buylla & de Alvarez-
Buylla, 1988; Koyama et al., 2000) and humans (Ward et al., 2009; Wehrwein et al., 2010). 
Whilst the suggestion, based on a correlative relation (Wehrwein et al., 2010), has been 
made that the stimulus to the CB during hypoglycaemia is most likely the fall in blood 
glucose concentration, there are other possibilities. For example, a number of counter-
regulatory endocrine or neuro-endocrine factors are released into the systemic circulation 
during hypoglycaemia including adrenaline, noradrenaline, cortisol and glucagon (Cryer, 
1993; Ward et al., 2007) or, indeed, insulin (Ribeiro et al., 2013) and any or all of these could 
be the stimulus that drives the observed increased ventilation (Bin-Jaliah et al., 2004, 2005) 
or corrective neuroendocrine reflexes (Koyama et al., 2000; Wehrwein et al., 2010). 
Consistent with the results identified in this article it is hypothesised therefore that one of 
these factors released as a consequence of hypoglycaemia may stimulate the CB rather 
than low glucose per se. Thus, whilst our data suggests that the intact CB may not act a 
direct glucosensor, we do not discount and fully support a key role for the organ in systemic 
glucose homeostasis. Future experiments may aim to fully characterise the importance of 
hormones in activating the CB and augmenting ventilation in hypoglycaemia. 
 
Concluding remarks 
The CB sustains normal sensory neuronal activity during prolonged exposure to glucose 
deprivation due to metabolism of stored glycogen that supports glycolysis and energy status. 
These findings therefore provide the first evidence of a physiological role for glycogen in the 
mammalian CB and question the ability of the in vivo CB to act as a sensor of acute changes 
in physiological blood glucose concentration. Disruption of glycogen or glucose metabolism 
in CB during pathology remains to be evaluated. 
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Figure 1. Carotid body sensory activity during prolonged exposure to glucose 
deprivation  
A) Example trace demonstrating the impact of prolonged glucose deprivation on the 
neuronal output of the intact CB. Basal discharge is maintained for at least 20 minutes 
before brief stimulation and then irreversible decline. Raw discharge is shown (upper) along 
with single fibre frequency (lower). Overdrawn action potentials portraying single fibre 
discrimination are shown inset. B) Mean discharge frequencies calculated at progressive 
time points during exposure to glucose deprivation. Error bars indicate ± SEM, * denotes 
P<0.05 compared with basal frequency; one way repeated measures ANOVA with Dunnett‟s 
post-hoc comparisons test. (N=8 fibres from 8 CB preparations). C) Example of the raw 
neuronal discharge taken from the same single fibre showing a 10 second period of maximal 
hypoxic (upper) and glucose free (lower) stimulation. D) Grouped data demonstrating that 
stimulation in response to glucose deprivation is significantly smaller than that induced by 
hypoxia. Error bars indicate + SEM. * denotes a significance of P<0.05 compared with 
hypoxia; paired t-test. (N=12 fibres from 8 CB preparations).  
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Figure 2. The time to a response in glucose deprivation is dependent on PO2-mediated, 
basal neuronal firing frequency.  
A) Example traces showing the sensory neuronal responses to glucose deprivation with 
increasing initial basal discharge frequencies (upper to lower). Moderate neuronal 
stimulation was induced by lowering and maintaining the superfusate PO2. Single fibre raw 
discharge was recorded and expressed in frequency histograms. For each trace multiple 
action potentials have been overdrawn to show the single fibre discrimination. B) Grouped 
data showing a correlation between basal frequency and the time taken to respond to 
glucose deprivation (R2=0.7, P<0.05; linear regression analysis. N=16 fibres from 13 CB 
preparations). 
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Figure 3. Glycogen granules and glycogen conversion enzymes are present in the rat 
carotid body. 
A) Immunofluorescent staining of CB tissue sections showing co-localisation of tyrosine 
hydroxylase (TH; type I cell marker) with glycogen synthase I and neuronal glycogen 
phosphorylase (BB) in the type I cells, across the entire CB (Scale bar = 100m). Staining 
was consistent across sections from 3 different CBs. B) Higher magnification fluorescence 
images of two different type I cell clusters, demonstrating co-localisation of TH with glycogen 
synthase I and neuronal glycogen phosphorylase (BB), specifically in the type I cell 
cytoplasm. There is also a degree of staining detected outside of type I cells for both 
glycogen conversion enzymes. Scale bar = 20m. C) Electron micrographs evidencing 
glycogen granules in the cytoplasm of multiple type I cells and in a neighbouring type II cell, 
within a single cluster. The higher magnification micrographs are of type I cells (middle and 
right). Scale bar = 5m (left), 2m (middle) and 1m (right).  
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Figure 4. Glycogen supports carotid body sensory activity during periods of 
prolonged glucose deprivation.  
 A) Glycogenolysis was targeted using a pharmacological inhibitor of glycogen 
phosphorylase; 4-Dideoxy-1, 4-imino D-arabinitol hydrochloride (DAB). Example traces of 
the sensory neuronal response to glucose deprivation are demonstrated in control CBs 
(upper) and in CBs treated with DAB (lower). Single fibre raw discharge was recorded and 
expressed in frequency histograms. Multiple action potentials have been overdrawn to show 
single fibre discrimination. B) Mean data showing that DAB significantly decreased the time 
to a response in glucose free. Error bars indicate + SEM, * denotes a significance level of 
P<0.05 compared with the time to a response in the control group; unpaired t-test. (N=14  
fibres, from 12 CB preparations-groups combined). C) Example trace showing the response 
to a glucose free stimulus following two 4-5 minute episodes of severe hypoxia. Severe 
hypoxia was applied to cause functional depletion of glycogen (see text). Raw neuronal 
discharge is shown (upper) along with frequency (lower). Inset: Multiple overdrawn action 
potentials demonstrating single fibre discrimination. D) Mean data showing that one or two 
exposures to severe hypoxia significantly decreased the time taken to respond to 
subsequent glucose deprivation. Error bars indicate + SEM. * denotes P<0.05 compared 
with control group and + P<0.05 compared with the post single hypoxic episode group; one 
way factorial ANOVA with Bonferroni post hoc analysis. (N=28 fibres from 19 CB 
preparations-groups combined).  
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Figure 5. Neuronal stimulation in glucose free conditions is dependent on a run-down 
in glycolysis  
A) Example trace demonstrating that 5 mM lactate and 0.5 mM pyruvate rapidly reverse the 
initial stimulation evoked by glucose deprivation. Raw discharge frequency from a single 
fibre is demonstrated (upper) along with frequency histograms (lower). Overdrawn action 
potentials demonstrate single fibre discrimination (inset). B) Mean data showing that the 
response to glucose deprivation is restored to basal levels by the addition of lactate and 
pyruvate. Data presented is from 9 fibres from 5 CB preparations. Error bars indicate + SEM, 
* denotes P<0.05 compared with basal frequency in 11 mM glucose; one way repeated 
measures ANOVA with Dunnett‟s post-hoc comparisons test. (N=9 fibres from 5 CB 
preparations). C) Example trace showing the effect of 1 mM glucose on the response to 
glucose deprivation. Raw neuronal discharge is shown (upper) along with frequency 
histograms (lower). Inset: Multiple action potentials have been overdrawn to show the single 
fibre discrimination. D) Mean data showing that addition of 1 mM glucose abolishes the 
response to initial glucose free stimulation. Error bars indicate + SEM. * denotes a 
significance of P<0.05 compared with the basal frequency in 11 mM glucose; one way 
repeated measures ANOVA with Dunnett‟s post-hoc comparisons test. (N=6 fibres from 3 
CB preparations). Note: for A) to D) experiments were performed following 5 minutes of 
severe hypoxia, to reduce the initial time to a response in glucose free (see earlier).  
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Figure 6. Carotid body responses to hypoxia are conserved during glucose 
deprivation 
A) Example recording of a CB sensory neuronal response to graded hypoxia in 11 mM 
glucose and glucose free conditions. The continuous superfusate PO2 is shown (upper) 
along with raw neuronal discharge (middle) and single fibre frequency histograms (lower) 
and demonstrate the preservation of the chemoafferent hypoxic response during glucose 
deprivation. Hypoxic responses were reversed before maximal discharge had been reached 
to restrict a run-down in the preparation. Graded hypoxia in glucose free conditions was 
induced after 10-15 minutes to ensure complete glucose washout. This was also prior to any 
stimulation or failure of the basal chemoafferent activity. B) The calculated mean discharge 
frequencies in 11 mM glucose and glucose free measured at selected levels of superfusate 
PO2 during hypoxia. Error bars indicate mean ± SEM; N=8 fibres from 6 CB preparations. C) 
An example recording demonstrating the impact of hypoxia and glucose free exposure on 
[Ca2+]i in a dissociated type I cell cluster. D) Grouped comparisons showing that glucose 
deprivation failed to evoke any acute type I cell excitation and had no effect on the [Ca2+]i 
response during hypoxia (N=9 cellular recordings from 3 CB preparations).  
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